1-4 of 4
life study
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab Plus Gemcitabine and Oxaliplatin (R-GemOx) in Refractory/Relapsed (R/R) DLBCL. a Real Life Study in Patients Ineligible for Autologous Transplantation

Clarisse Cazelles, Karim Belhadj, Helene Vellemans, Vincent Camus, Christiane Copie, MD PhD, Liana Veresezan, MD, Emmanuel Itti, MD PhD, Stephanie Becker, MD, Muriel verlinde Carvalho, Jehan Dupuis, MD, Fabien Le Bras, Francois Lemonnier, MD PhD, Louise Roulin, MD, Taoufik El Gnaoui, Fabrice Jardin, Nicolas Mounier, MD, Herve Tilly, MD PhD, Corinne Haioun, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4115.
https://doi.org/10.1182/blood-2019-124143
Published: 2019
Journal Articles

Miroir: A National, Multicenter, Non-Interventional Study of Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM) Treated with Pomalidomide (POM) in France

Cyrille Hulin, MD, Margaret Macro, MD, Sophie Gourgou, Bertrand Arnulf, MD PhD, Florence Lachenal, Caroline Lenoir, Anne-Marie Stoppa, MD, Marie Lorraine Chretien, Laure Vincent, Aurore Perrot, MD, Philippe Moreau, MDPhD, Lionel Karlin, MD, Cécile Fohrer, Jean-Richard Eveilard, Jean Fontan, MD, Olivier Decaux
Journal: Blood
Blood (2017) 130 (Supplement 1): 1848.
https://doi.org/10.1182/blood.V130.Suppl_1.1848.1848
Published: 2017
Journal Articles

Clinical Outcomes of 420 MDS Patients Treated with 5-Azacytidine: Evaluation of Overall Survival, Duration of Treatment and Rate of Discontinuation in a Real Life Study from the Italian MDS Registry of Fondazione Italiana Sindromi Mielodisplastiche (FISM)

Marino Clavio, MD, Daniela Gioia, MD, Manuela Ceccarelli, MD, Chiara Monagheddu, MD, Enrico Balleari, MD, Maurizio Miglino, PhD, Anna Angela Di Tucci, Bernardino Allione, MD, Antonella Poloni, MD, Carlo Finelli, MD, Chiara Aguzzi, MD, Carmine Selleri, MD, Paolo Danise, MD, Daniela Cilloni, MD, Valentina Gaidano, MD, Marina Cavaliere, MD, Tullio Calzamiglia, MD, Roberto Freilone, MD, Gianni Cametti, MD, Anna Rita Conconi, MD, Mauro Mezzabotta, MD, Riccardo Goretti, MD, Pellegrino Musto, MD, Gianluca Gaidano, MD, Fabrizio Pane, MD, Emanuele Angelucci, MD, Alessandro Levis, MD, Valeria Santini, MD
Journal: Blood
Blood (2016) 128 (22): 4341.
https://doi.org/10.1182/blood.V128.22.4341.4341
Published: 2016
Journal Articles

Outcome of Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and/or 17p Deletion/ TP 53 Mutations Treated with Ibrutinib According to a Named Patient Program (NPP) in Italy: Preliminary Analysis of a Real Life Retrospective Study

Francesca Romana Mauro, MD PhD, Alessandra Tedeschi, Alfonso Piciocchi, BS, Marina Motta, MD, Emilia Iannella, MD, Lucia Farina, MD PhD, Lydia Scarfo, Roberto Marasca, MD, Marta Coscia, MD PhD, Agostino Cortelezzi, MD, Luca Laurenti, Angela Melpignano, MD, Pier Luigi Zinzani, MD PhD, Stefano Molica, MD, Francesca Re, MD, Alessandro Andriani, MD, Donatella Iolanda Vincelli, MD, Carlo Visco, MD, Alessandro Gozzetti, MD, Ester Maria Orlandi, MD, Livio Trentin, MD, Monica Tani, Catello Califano, MD, Giuseppe Tagariello, MD, Paolo Ghia, MD PhD, Maria Denise Caputo, MD, Adriano Salaroli, MD, Idanna Innocenti, MD, Anna Frustaci, MD, Candida Vitale, MD, Marta Petullà, PharmD, Paolo de Fabritiis, MD, Marco Vignetti, MD, Paola Fazi, MD, Robin Foà
Journal: Blood
Blood (2016) 128 (22): 2038.
https://doi.org/10.1182/blood.V128.22.2038.2038
Published: 2016